The Business of Living Longer

​ Longevity has moved from fringe to front page. Large raises are being announced, companies are being built, and physicians are rethinking what preventive care actually means.

​On May 4th, Forum Ventures and Mount Sinai Innovation Partners are hosting a private breakfast in New York City to have that conversation — a discussion between all stakeholders in the business of longevity and preventative care.

​You'll hear from investors alongside physicians, industry experts, and founders building at the frontier of this space.

​​​​​​Request a spot to join and get access to the location.

​We'll be exploring

• ​What's real, what's hype, and where is the smart money actually going?

• ​Where are the real growth and investment opportunities in longevity?

​Ideal Guests

​Investors, physicians, founders, and operators with a stake in the longevity and preventive care landscape.

​Approved Guests

​​​​Application DOES NOT guarantee attendance. ​​Spaces for this event are limited to maintain the quality of interactions and aim to ensure every participant receives optimum value.

​​​​Admitted guests will be notified via event approval (with a calendar invite).

​​About Forum Ventures

​​​​​​Forum Ventures is the leading early-stage fund, accelerator and AI venture studio for B2B startups. Founded in 2014, we’re on a mission to make the journey easier, more accessible, and successful for early-stage founders.

​​​​​​Forum is investing in 85 startups this year. Pitch Us here.

​​​We’re also launching 8 new companies in our venture studio. If you’ve lived a real pain point and have an idea you’re ready to build, tell us why you’d be a great founder for our AI Venture Studio.

​​About Mount Sinai Innovation Partners

​Mount Sinai Innovation Partners (MSIP) facilitates the real-world application and commercialization of Mount Sinai Heath System discoveries and the development of research partnerships.

​​​​Brought to you by Brown Rudnick

​Brown Rudnick is an international law firm with over 75 years of experience, specializing in high-stakes litigation, crisis management, and complex business transactions for tech and life sciences clients.

​Founded in 1948 with roots in Boston and New York, it has expanded to include London and other key U.S. cities, operating with roughly 225 attorneys.